Trifarotene

(Aklief®)

Trifarotene

Drug updated on 11/14/2023

Dosage FormCream (topical: 0.005%)
Drug ClassRetinoids
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the topical treatment of acne vulgaris in patients 9 years of age and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Aklief (trifarotene) Prescribing Information.2019Galderma Laboratories, L.P., Fort Worth, TX

Systematic Reviews / Meta-Analyses

Document TitleYearSource
Trifarotene for the Treatment of Facial and Truncal Acne. 2021The Annals of pharmacotherapy.